X
Record #60017

Designing of SiO2 mesoporous nanoparticles loaded with mometasone furoate for potential nasal drug delivery: Ex vivo evaluation and determination of pro-inflammatory interferon and interleukin mRNA expression.

Publisher
Frontiers
Original paper date
Jan 6, 2023
Institution
Riphah Institute of Pharmaceutical Sciences (RIPS), Riphah International University Faisalabad, Faisalabad, Pakistan · Saffron Pharmaceuticals (Pvt.) Ltd., Faisalabad, Pakistan · Department of Pharmacology, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad, Pakistan · Faculty of Pharmacy, University of Lahore, Lahore, Pakistan · Rashid Latif College of Pharmacy, Rashid Latif Khan University, Lahore, Pakistan · Chitkara College of Pharmacy, Chitkara University, Chandigarh, Punjab, India · Department of Rasa Shastra and Bhaishajya Kalpana, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India · Department of Chemistry, Faculty of Science, University of Hradec Králové, Hradec Králové, Czechia · Neurology Clinic, University Hospital, Hradec Králové, Czechia · Biomedical Research Center, University Hospital Hradec Kralove, Hradec Králové, Czechia · Department of Neurology, Charles University in Prague, Faculty of Medicine in Hradec Králové and University Hospital, Hradec Králové, Czechia · Department of Pharmacy, BGC Trust University Bangladesh, Chittagong, Bangladesh · Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh
Open access
No
Article type
Research Article
Broad categories
(BLS) Biochemistry(BLS) Genetics(HSC) Medicine - Drug Design(PHY) Nanotechnology
Notes from Retraction Watch

see also: https://pubpeer.com/publications/3C7439FB742521CDC3AA7189A49905

Citation lifecycle

How this paper is being cited

Pre-retraction
8
Same day
0
Post-retraction
5
% post-retraction
38.5%
~4.1 citations/yr before retraction · ~2.8 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse